South San Francisco-based biotechnology company Surrozen, Inc. (Nasdaq: SRZN) will participate in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The presentation is scheduled for September 10th.
Company leadership will discuss Surrozen‘s advancements in its pipeline of targeted therapeutics. The company focuses on selectively modulating the Wnt pathway to treat severe eye diseases.
The presentation will begin at 8:30 AM Pacific Time, or 11:30 AM Eastern Time. Individuals interested in the presentation can access a live audio webcast through the investor relations section of the Surrozen website.
A recording of the webcast will be available on the website following the event’s conclusion. This allows those unable to attend live to review the information at their convenience.
Surrozen is committed to developing tissue-specific antibodies to selectively target the Wnt pathway. Their work centers on ophthalmology, leveraging the body’s natural repair mechanisms to address severe eye diseases.
The company’s research and development efforts are focused on creating novel treatments with the potential to improve patient outcomes significantly. Further details regarding the specific compounds and clinical trial data presented at the conference are expected to be released following the event.
The company’s statements regarding future plans, including clinical development timelines and the potential benefits of its product candidates, are considered forward-looking statements. Such statements involve inherent risks and uncertainties. Actual results may differ from expectations due to various factors, including those discussed in Surrozen‘s filings with the Securities and Exchange Commission (SEC). These filings include the company’s 10-K and 10-Q reports. Investors should not place undue reliance on these forward-looking statements. Surrozen does not assume any obligation to update these statements unless required by law.
Investors and media can contact Surrozen through the investor relations email address provided on the company website.
Related
